pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,153 catalysts · 4,876 phase readout · 2,347 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 9 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×type: approval×clear all
type
  • phase readout4,876
  • 8k filing2,347
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07607054: A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.

    Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.. Phase: PHASE1. Conditions: Locally Advanced or Metastatic Solid Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06482905: Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

    Sponsor: Tcelltech Inc.. Phase: PHASE1. Conditions: High-grade Glioma, WHO Grade Ⅳ Glioma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03552705: The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients

    Sponsor: Stanford University. Phase: PHASE2. Conditions: Anterior Cruciate Ligament Reconstruction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07483294: Cerebellum-based Imaging Neural Markers for Antipsychotic Response

    Sponsor: Northwell Health. Phase: PHASE4. Conditions: Psychosis; Acute

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07335666: Virtual Reality Outperforms Game Card Distraction in Reducing Distress During Pediatric Wound Care

    Sponsor: Agri Ibrahim Cecen University. Phase: NA. Conditions: Pediatric Wounds, Procedural Pain, Procedure-Related Anxiety, Procedural Fear

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05403151: Controls and Healthy Vasculature Initiative

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Vascular And Immunologic Diseases, Healthy Volunteers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06493851: The Effect of Hyperbaric Oxygen Therapy for Acceleration Recovery After Anterior Cruciate Ligament Reconstruction(ACLR)

    Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Anterior Cruciate Ligament Reconstruction

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06779851: A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors

    Sponsor: Bright Peak Therapeutics Inc. Phase: PHASE1. Conditions: Advanced Solid Tumors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT05860751: The Effect of Dry Needling With Electrical Stimulation on Individuals With Restless Legs Syndrome

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Neck Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05794451: Developing an Artificial Intelligence System to Detect Cognitive Impairment

    Sponsor: University of Haifa. Phase: . Conditions: Alzheimer Disease, Healthy Aging, Mild Cognitive Impairment

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00337051: Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)

    Sponsor: University Hospital, Bordeaux. Phase: PHASE3. Conditions: End-stage Chronic Renal Disease, Severe Acute Kidney Failure, Renal Transplantation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03390751: Atropine Weight and Risk of Postoperative Confusion in the Elderly

    Sponsor: University Hospital, Toulouse. Phase: . Conditions: Aging

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07225751: A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

    Sponsor: Kuros Biosurgery AG. Phase: NA. Conditions: Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion, Ankle Deformity, Ankle Disease, Hindfoot Arthrodesis, Hindfoot Pathologies

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06448351: Manipulating E-Cigarette Nicotine to Promote Public Health

    Sponsor: Ohio State University Comprehensive Cancer Center. Phase: NA. Conditions: Tobacco-Related Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00659529: Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease

    Sponsor: National Jewish Health. Phase: PHASE1. Conditions: Cystic Fibrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00473031: The Effect of Weight Loss and Dietary Protein Intake on Bone

    Sponsor: Rutgers University. Phase: NA. Conditions: Weight Loss, Bone Density

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07421453: Implementation of an Enhanced Recovery Pathway for Burr-hole Drainage in Patients With a Chronic Subdural Hematoma

    Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: . Conditions: Chronic Subdural Hematoma, Chronic Subdural Hematomas

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02476253: Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill

    Sponsor: University Hospital, Montpellier. Phase: PHASE3. Conditions: Metabolic Acidosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02086253: Role of Endothelin-1 in Flow-mediated Dilatation

    Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Healthy Conditions

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06975553: Extubation Safety Via Microstream EtCO₂ (IPI) Monitoring

    Sponsor: Chinese PLA General Hospital. Phase: NA. Conditions: Hypoxemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07630597: Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Lifestyle Intervention

    Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School. Phase: NA. Conditions: Obesity & Overweight

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06825897: Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe

    Sponsor: Santiago Ortega Gutierrez. Phase: NA. Conditions: Stroke, Acute

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT04159597: Expanded Access to Upadacitinib

    Sponsor: AbbVie. Phase: . Conditions: Crohn Disease, Ulcerative Colitis, Idiopathic Arthritis (Including sJIA, pJIA, or JPsA), Atopic Dermatitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06658197: Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

    Sponsor: Xuanwu Hospital, Beijing. Phase: PHASE3. Conditions: Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain, Drug Effect

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07216560: First-in-human Study of 7MW4911 in GI Cancer

    Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.. Phase: PHASE1. Conditions: GI Cancers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07461220: Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy

    Sponsor: Integrative Research Laboratories AB. Phase: PHASE1. Conditions: PARKINSON DISEASE (Disorder), Apathy, Safety

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05600920: A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Idiopathic CD4 Lymphopenia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05634720: Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

    Sponsor: Duke University. Phase: PHASE4. Conditions: Pancreatic Ductal Adenocarcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05571982: Comparison of the Efficacy of Tidal Volume Breathing and Vital Capacity Breathing During High-flow Nasal Oxygen

    Sponsor: Yonsei University. Phase: NA. Conditions: Adult Patients 20 Years of Age or Older Who Are Planning to Undergo Surgery Under General Anesthesia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06384924: Raman Spectroscopy and Skin Cancer

    Sponsor: Tiezhi Zhang. Phase: . Conditions: Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07622459: Circadian Feeding and Reciprocal Scent Intervention in NICU

    Sponsor: Inonu University. Phase: NA. Conditions: Prematurity, Mechanical Ventilation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03325959: Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome

    Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Fibromyalgia, Hyperbaric Oxygen

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07469059: Characterization of Renal Microvascular Alterations in Patients With Active Urinary Sediment and/or Proteinuria Using Ultrasound Localization Microscopy

    Sponsor: University of Erlangen-Nürnberg Medical School. Phase: . Conditions: Nephritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06587880: The Effect of Different Types of Mouthwash on Extraction Sockets' Healing

    Sponsor: University of Jordan. Phase: PHASE4. Conditions: Extraction Socket Healing, Quality of Life, Postoperative Complications

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03869996: Total Knee Arthroplasty: Fast Track Protocol is the Future?

    Sponsor: Istituto Ortopedico Rizzoli. Phase: NA. Conditions: Osteoarthritis, Knee, Arthropathy of Knee

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07604727: AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation

    Sponsor: University Medical Center Groningen. Phase: NA. Conditions: Atrial Fibrillation (AF), Heart Failure, Cardiac Pacing

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04716127: A Proximity-incentive Strategy for Cervical Cancer Screening

    Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Cervical Cancer, Uterine Cervical Disease, Human Papilloma Virus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05508061: Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

    Sponsor: Inreda Diabetic B.V.. Phase: NA. Conditions: Type 1 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02629042: Efficacy of Oral Prednisolone on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis

    Sponsor: University Hospital, Bordeaux. Phase: PHASE3. Conditions: Pulpitis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07624786: Patient-Ventilator Asynchrony: Occurence and Clinical Impact in Usual Care

    Sponsor: Erasmus Medical Center. Phase: . Conditions: Mechanical Ventilation, Patient-Ventilator Asynchrony

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06679270: Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

    Sponsor: Amryt Pharma. Phase: PHASE3. Conditions: Familial Partial Lipodystrophy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07214870: A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

    Sponsor: Novo Nordisk A/S. Phase: PHASE1. Conditions: Fatty Liver Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07560969: Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans

    Sponsor: University of Missouri, Kansas City. Phase: NA. Conditions: Diabetes, Physical Activity, Food Security, Nutrition Security

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07270783: Healthy Volunteer Study

    Sponsor: InventisBio Co., Ltd. Phase: PHASE1. Conditions: Healthy Volunteer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06456983: Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial

    Sponsor: Central Institute of Mental Health, Mannheim. Phase: NA. Conditions: Schizophrenia, Treatment Resistant Schizophrenia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04602741: Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Schizophrenia, Schizo Affective Disorder, Psychotic Disorders

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT03588754: Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?

    Sponsor: Yale University. Phase: PHASE2. Conditions: Alcohol Drinking

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06144554: Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

    Sponsor: Insulet Corporation. Phase: . Conditions: Type 1 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01581554: Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05012254: Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

    Sponsor: Fundación GECP. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer

    full page →ctgov ↗
    ← prev
    page 66 of 104
    next →